Selection of retroviral reverse transcription primer is coordinated with tRNA biogenesis

Journal of Virology

Volumn 77, Issue 16, 2003, Pages 8695-8701

  Kelly, Nathan J ^a   Palmer, Matthew T ^b   Morrow, Casey D ^b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRIMER RNA; TRANSFER RNA;

ACYLATION; ARTICLE; BIOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RETROVIRUS; REVERSE TRANSCRIPTION; RNA TRANSPORT; VIRUS INFECTIVITY;

BASE SEQUENCE; CELL LINE; GENETIC COMPLEMENTATION TEST; HIV; HUMANS; MUTATION; NUCLEIC ACID CONFORMATION; RNA; RNA, TRANSFER, PHE; SACCHAROMYCES CEREVISIAE; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 0042709464     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.16.8695-8701.2003     Document Type: Article

References (32)

1. Arts, G.-J., S. Kuersten, P. Romby, B. Ehresmann, and I. W. Mattaj. 1998. The role of exportin-t in selective nuclear export of mature tRNAs. EMBO J. 17:7430-7441.
2. Cen, S., A. Khorchid, H. Javanbakht, J. Gabor, T. Stello, K. Shiba, K. Musier-Forsyth, and L. Kleiman. 2001. Incorporation of lysyl-tRNA synthetase into human immunodeficiency virus type 1. J. Virol. 75:5043-5048.
3. Cimarelli, A., and J. Luban. 1999. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein. J. Virol. 73:5388-5401.
4. Colicelli, J., and S. P. Goff. 1987. Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA. J. Virol. 57:37-45.
5. Lys. J. Virol. 69:3090-3097.
6. Gilboa, E., S. W. Mitra, S. Goff, and D. Baltimore. 1979. A detailed model of reverse transcription and tests of crucial aspects. Cell 18:93-100.
7. Gorlich, D., and U. Kutay. 1999. Transport between the cell nucleus and the cytoplasm. Annu. Rev. Cell Dev. Biol. 15:607-660.
8. Harada, F., R. C. Sawyer, and J. E. Dahlberg. 1975. A primer ribonucleic acid for initiation of in vitro Rous sarcoma virus deoxyribonucleic acid synthesis. J. Biol. Chem. 50:3487-3497.
9. Ho, Y.-S., and Y. W. Kan. 1987. In vivo aminoacylation of human and Xenopus suppressor tRNAs constructed by site-specific mutagenesis. Proc. Natl. Acad. Sci. USA 84:2185-2188.
10. Lys3 aminoacylation and its incorporation into HIV-1. J. Biol. Chem. 277:17389-17396.
11. Met. J. Virol. 71:207-217.
12. Phe expressed in human cells can be selected by HIV-1 for use as a reverse transcription primer. Virology, in press.
13. Li, X., J. Mak, E. J. Arts, Z. Gu, L. Kleiman, M. A. Wainberg, and M. A. Parniak. 1994. Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication. J. Virol. 68:6198-6206.
14. Lobo, S. M., and N. Hernandez. 1989. A 7 bp mutation converts a human RNA polymerase II snRNA promoter into an RNA polymerase III promoter. Cell 58:55-67.
15. Lund, A. H., M. Duch, J. Lovmand, P. Jorgensen, and F. S. Pedersen. 1997. Complementation of a primer binding site-impaired murine leukemia virus-derived retroviral vector by a genetically engineered tRNA-like primer. J. Virol. 71:1191-1195.
16. Mak, J., and L. Kleiman. 1997. Primer tRNAs for reverse transcription. J. Virol. 71:8087-8095.
17. Marquet, R., C. Isel, C. Ehresmann, and B. Ehresmann. 1995. tRNAs as primers of reverse transcriptases. Biochimie 77:113-124.
18. Negrutskii, B. S., and M. P. Deutscher. 1991. Channeling of aminoacyl-tRNA for protein synthesis in vivo. Proc. Natl. Acad. Sci. USA 88:4991-4995.
19. Ott, D. E., L. V. Coren, D. G. Johnson, B. P. Kane, R. C. I. Sowder, Y. D. Kim, R. J. Fisher, X. Z. Zhou, K. P. Lu, and L. E. Henderson. 2000. Actin-binding cellular proteins inside human immunodeficiency virus type 1. Virology 266:42-51.
20. Parry, H. D., and I. W. Mattaj. 1990. Positive and negative functional interactions between promoter elements from different classes of RNA polymerase III-transcribed genes. EMBO J. 9:1097-1104.
21. Peters, G., F. Harada, J. E. Dahlberg, A. Panet, W. A. Haseltine, and D. Baltimore. 1977. Low-molecular-weight RNAs of Moloney murine leukemia virus: identification of the primer for RNA-directed DNA synthesis. J. Virol. 21:1031-1041.
22. Lys primer-binding site of human immunodeficiency virus type 1 identify essential regions for reverse transcription. J. Virol. 65:4555-4564.
23. Phe by its cognate yeast phenylalanyl-tRNA synthetase: an analysis of specificity. Biochemistry 31:4161-4167.
24. Stapulionis, R., and M. P. Deutscher. 1995. A channeled tRNA cycle during mammalian protein synthesis. Proc. Natl. Acad. Sci. USA 92:7158-7161.
25. Varmus, H. 1988. Retroviruses. Science 240:1427-1435.
26. Lys,3. J. Virol. 69:6021-6029.
27. Whitcomb, J. M., B. A. Ortiz-Conde, and S. H. Hughes. 1995. Replication of avian leukosis viruses with mutations at the primer binding site: use of alternative tRNAs as primers. J. Virol. 69:6228-6238.
28. Wolin, S. L., and A. G. Matera. 1999. The trials and travels of tRNA. Genes Dev. 13:1-10.
29. Yu, Q., and C. D. Morrow. 1999. Complementarity between 3′ terminal nucleotides of tRNA and primer binding site is a major determinant for selection of the tRNA primer used for initiation of HIV-1 reverse transcription. Virology 254:160-168.
30. Yu, Q., and C. D. Morrow. 2000. Essential regions of the tRNA primer required for HIV-1 infectivity. Nucleic Acids Res. 28:4783-4789.
31. Yu, Q., and C. D. Morrow. 2001. Identification of critical elements in the tRNA acceptor stem and TΨC loop necessary for human immunodeficiency virus type 1 infectivity. J. Virol. 75:4902-4906.
32. His. Virology 226:306-317.